Posted on

The Secretary of Health (SOH) acknowledges the final recommendation of the HTA Council on ceftaroline fosamil (600 mg powder for concentrate for solution for injection) for the treatment of community-acquired pneumonia (CAP) in the pediatric population (date of receipt of acknowledgment: 13 January 2026). As a final recommendation, the HTA Council does not recommend the government financing of ceftaroline fosamil for the treatment of community-acquired pneumonia (CAP) in the pediatric population.

For further details, please refer to the documents below:

[HTAC Final Recommendation] Ceftaroline fosamil for CAP of pediatric populationDownload
[Evidence Slides] Ceftaroline Fosamil for CAP in Pediatric PopulationDownload